Would you like information regarding Nova Oculus or Macular Degeneration?

If you or someone you know is affected by Age Related Macular Degeneration, and you would like to receive a brochure regarding Nova Oculus, please contact us for more information.

Frequently asked Questions:

Who is Nova Oculus Partners, LLC?
Nova Oculus Partners, LLC. was formed in early 2014 to develop, manufacture, and lease to medical professionals, primarily optometrists, a medical device to treat macular degeneration by delivering low-level electric current to the eye, mitigating the effects of age-related macular degeneration and diabetic retinopathy..
How does this procedure work?
Using our device, each procedure takes approximately 32 minutes and consists of a 40 cycle treatment of micro-current stimulation applied to four sites around the eyes (upper left lid, lower left lid, upper right lid and lower right lid) for 40 seconds at each site, simultaneously.
Is the Nova Oculus Device Safe?
Yes. The Nova Oculus II device has been certified as complying with the quality management standard set by the International Organization of Standardization (ISO) and the electrical safety standard set by the International Electrotechnical Commission (IEC). These global certifications pave the way for regulatory approvals for Nova Oculus worldwide.
Is there a cure for Macular Degeneration?
AGE-RELATED macular degeneration has no cure. It is the No. 1 cause of severe vision loss and legal blindness in adults over 60 in North America. More than 15 million North Americans suffer from this affliction — a figure that is expected to double as baby boomers age.
What is the company’s revenue model?
We will lease the machine to eye-care practitioners for a fixed cost. However, the bulk of our revenue (more than 90%) will come from royalties on every treatment applied to a patient. The number of treatments will be tracked online to ensure accurate billing.
Do the treatments need to be applied by an eye-care professional?
A technician can be trained to apply the treatments under the supervision of the Optometrist.
Does the body build a tolerance to the electrotherapy treatment?
Clinical studies involving electrotherapy procedures that have been reported in scientific literature have not reported any evidence of a tolerance forming to repeated treatments with microcurrent treatments.
Can you offer any hope to patients afflicted with dry macular degeneration (AMD)?
Yes. The Nova Oculus II device will revolutionize the treatment protocols for dry AMD and offer hope to millions of patients who are otherwise going blind without it. Though dry AMD is an affliction without a cure, the Nova Oculus company’s patented micro-current electro- therapy technology is proving to successfully mitigate its symptoms.
What kind of results can patients expect from macular degeneration treatments?
Using technology developed by Dr. O’Clock patients can experience visual improvements during the first week of treatments (dependent on how badly damaged the eyes are).
Are the results of the treatment permanent?
No. The Nova OculusTM device will VASTLY improve the patients’ eye sights, however the patient will have to use the device for the rest of their life & will improve visual acuity after each treatment session.

Contact Us